Hypercoagulability and clinical thrombosis-venous, arterial, and embolic, are common clinical problems requiring rapid diagnosis and treatment. The identification of new blood protein defects leading to both arterial and venous thrombosis, combined with clinical evaluation of the patient, allows for approximately 80% of individuals suffering a thrombotic or thromboembolic event to have the definitive causes identified.